VVT Med advances Portugal entry as Dermworks starts ScleroSafe evaluation
VVT Med says Dermworks will begin ScleroSafe® market evaluation, with initial physician demonstrations and market research planned following earlier independent physician experience in Portugal.
VVT Med Inc. said Dermworks has placed an initial order for ScleroSafe, and market research and initial physician demonstrations are set to begin after earlier independent physician experience in Portugal. The company said the work follows earlier independent physician experience in Portugal. The source line is dated Sept.
1, 2026.